Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy.
Am J Trop Med Hyg. 2021 Nov 15;106(2):639-642. doi: 10.4269/ajtmh.21-0600.
The management of visceral leishmaniasis (VL) in HIV-infected patients is complex because of high mortality rates, toxic drug-related side effects, and a high risk of treatment failure and relapse. We report a case of active chronic VL in an HIV-1-infected woman presenting multiple secondary VL episodes over 7 years leading to massive splenomegaly and blood transfusion-dependent anemia despite several treatment courses and secondary prophylaxis. The patient was finally successfully treated with rescue treatment based on intravenous pentamidine. Twenty months after discontinuation of pentamidine the patient presented complete clinical and parasitological response. In patients with active chronic VL, treatment with intravenous pentamidine can be effective and should be considered as rescue treatment.
HIV 感染者内脏利什曼病(VL)的管理很复杂,因为死亡率高、药物相关毒性副作用以及治疗失败和复发的风险高。我们报告了一例 HIV-1 感染妇女的活动性慢性 VL 病例,该患者在 7 年中多次出现继发性 VL 发作,导致巨脾和依赖输血的贫血,尽管进行了多次治疗和二级预防。最终,该患者通过基于静脉注射戊烷脒的抢救治疗成功治愈。在停止注射戊烷脒后 20 个月,患者出现完全的临床和寄生虫学应答。对于活动性慢性 VL 患者,静脉注射戊烷脒治疗可能有效,应考虑作为抢救治疗。